Health
Researchers to test monoclonal antibodies against COVID-19 – Mirage News
Getty Images “We need a treatment that is effective,” said infectious disease physician Ann Collier, who is leading the trial at UW Medicine. UW…
UW Medicine is one of a network of U.S. sites testing a new treatment for COVID-19 that involves monoclonal antibodies, which are intended to provide immediate antiviral activity that lasts several weeks.
The drug is part of the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, sponsored by the National Institute of Allergy and Infectious Diseases. The trial is also receiving support from Operation Warp Speed, the U.S. government’s multi-agency effort to help end the pandemic….
-
Noosa News24 hours agoWoman charged with Mark Akers’s murder after body found on roadside
-
General21 hours agoMaría Corina Machado awarded Nobel Peace Prize
-
Business9 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
Noosa News20 hours agoQueensland’s bid for net zero by 2050 unlikely under new energy plan: expert